SEC Form D private-offering filing
Blue Marlin Therapeutics, Inc.
A new SEC Form D private-offering notice from Charlottesville, VA, an undisclosed offering target in Biotech. The source filing is one click away.
Preclinical biotech developing non-viral, antibody-targeted technology to engineer immune cells directly in the body.
Filed 2025-10-21Filed to raise UndisclosedFirst money in 2025-10-06Raised so far $100,000HQ (as filed) Charlottesville, VASector Biotech ✓Stage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified bluemarlin.bio↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.